Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset

Ferrannini, Ele, Mari, Andrea, Nofrate, Valentina, Sosenko, Jay M., Skyler, Jay S., for the DPT-1 Study Group·2010·Diabetes
DOI 10.2337/db09-1378

Cited by (141)

Items 101–141 of 141

  1. Pancreatic β-cell dysfunction in normoglycemic patients and risk factors
    Luis H. Vilchis-Flores, Georgina A. Barajas-Medina, Ana Villa-Martínez, Sara S. Salazar López, Gabriela Aidee Luna-Patiño, María Elena Quiroz-Hernández, María Alejandra Guzmán-Vanegas, Rafael Rodríguez-Cortés, Fabiola Angulo-Romero, María de Lourdes Reyes‐Escogido et al. · 2019 · Acta Diabetologica
  2. Optimized Human Regular U-500 Insulin Treatment Improves β-Cell Function in Severely Insulin-Resistant Patients with Long-Standing Type 2 Diabetes and High Insulin Requirements
    Andrea Mari, Julio Rosenstock, Xiaosu Ma, Ying Grace Li, Jeffrey A. Jackson · 2015 · Endocrine Practice
  3. The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk
    Heba M. Ismail, David D Cuthbertson, Stephen Eric Gitelman, Jay S. Skyler, Andrea K. Steck, Henry Rodriguez, Mark A. Atkinson, Brandon M. Nathan, MARIA JOSE REDONDO, Kevan C. Herold et al. · 2022 · Diabetes Care
  4. New Perspectives in Studying Type 1 Diabetes Susceptibility Biomarkers
    Y.B. Park, Kyung Soo Ko, Byoung Doo Rhee · 2025 · International Journal of Molecular Sciences
  5. PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes
    Jaquellyne Gurgel Penaforte-Saboia, Carlos Eduardo Barra Couri, Natasha Vasconcelos Albuquerque, Lana Lívia Peixoto Linard, Daniel Mendes Pereira Ardisson Araújo, Sherida de Oliveira, Thisciane Gomes, Marcelo Maia Pinheiro, Maria Helane da Costa Gurgel Castelo, Virgínia Oliveira Fernandes et al. · 2024 · Diabetes Metabolic Syndrome and Obesity
  6. Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop
    Carla J. Greenbaum, Gerald T. Nepom, Lauren K. Wood Heickman, Diane K. Wherrett, Linda Anne DiMeglio, Kevan C. Herold, Jeffrey P. Krischer · 2024 · Diabetes
  7. Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts français
    Roberto Mallone, Élise Bismuth, Charles Thivolet, Pierre‐Yves Benhamou, Nadine Hoffmeister, François Collet, Marc P Nicolino, Rachel Reynaud, Jacques Beltrand, Jacques Beltrand et al. · 2024 · Médecine des Maladies Métaboliques
  8. Islet cells in human type 1 diabetes: from recent advances to novel therapies – a symposium-based roadmap for future research
    James Cantley, Decio Laks Eizirik, Esther Latres, Colin Mark Dayan, _ _ · 2023 · Journal of Endocrinology
  9. Nanomedicine’s transformative impact on anti-diabetic drug discovery: an appraisal
    Kunika Saini, Smriti Sharma · 2023 · Journal of Nanoparticle Research
  10. Deterioration of insulin release rate response to glucose during oral glucose tolerance test is associated with an increased risk of incident diabetes in normal glucose tolerance subjects
    Yuanyuan Li, Shi-Hui He, Yao Sun, Guangwei Li, Qingsong Xu, Chen Wang, Weiping Jia · 2017 · IUBMB Life
  11. Expression of Human Mutant Preproinsulins Induced Unfolded Protein Response, Gadd45 Expression, JAK-STAT Activation, and Growth Inhibition in Drosophila
    Tatsuki Yamazoe, Yasuyuki Nakahara, Hiroka Katsube, Yoshihiro H. Inoue · 2021 · International Journal of Molecular Sciences
  12. β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes
    Stephen Eric Gitelman, Carmella Evans‐Molina, Annamaria Guolo, Andrea Mari, Ele Ferrannini · 2023 · Diabetes
  13. Successes and Disappointments with Clinical Islet Transplantation
    Paolo Cravedi, Piero Luigi Ruggenenti, Giuseppe Remuzzi · 2013 · Springer eBooks
  14. T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes
    Perrin Guyer, Kapitolina Seminova, Marija Lugar, Anthony Manganaro, Erandi Velarde de la Cruz, Rachel Hartley, Megan E. Smithmyer, Cate Speake, Ezio E. Bonifacio, Sally C. Kent et al. · 2025 · Diabetologia
  15. A Role for lncRNAs in Regulating Inflammatory and Autoimmune Responses Underlying Type 1 Diabetes
    Thomas C. Brodnicki · 2022 · Advances in experimental medicine and biology
  16. New insights into halting type 1 diabetes
    Jay S. Skyler · 2021 · The Lancet Diabetes & Endocrinology
  17. C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’?
    Richard David Leslie, Tanwi Vartak · 2019 · BMC Medicine
  18. Assessment of peridontal vessels hemodynamics among patients with diabetes mellitus type 1
    L. Yu. Orekhova, R. S. Musaeva, Екатерина Сергеевна Лобода, Е. V. Grinenko, G. Yu. Gulyanov · 2020 · Pediatric dentistry and dental prophylaxis
  19. Prevention of Type 1 Diabetes
    Jay S. Skyler · 2018 · Endocrinology
  20. Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset
    Carmella Evans‐Molina, Stephen Eric Gitelman, Andrea Mari, Ele Ferrannini · 2026 · Diabetologia
  21. Insulin Secretion and Insulin Sensitivity Change in Different Stages of Adult-Onset Type 1 Diabetes: A Cross-Sectional Study
    Tanja J. Milicic, Aleksandra Jotić, Katarina S. Lalic, Ljiljana Lukić, Marija V. Macesic, Jelena Stanarčić Gajović, Milica M. Stoiljkovic, Mina M. Milovancevic, Djurdja P. Rafailovic, Aleksandra Božović et al. · 2025 · Journal of Clinical Medicine
  22. Pathogenesis of Type 1 Diabetes
    Alberto Pugliese · 2018 · Endocrinology
  23. Immunopathogenesis of type 1 diabetes in Western society
    Alberto Pugliese · 2015 · Wiley eBooks
  24. Therapeutic effects of Desmodium uncinatum on streptozotocin-induced diabetes in Wistar rats: modulation of hyperglycemia, inflammation, and oxidative stress
    Jordane Waguia Kamgaing, Sylviane Laure Poualeu Kamani, Moïse Legentil Nchouwet, Rostand Cyrille Djimeli Douho, Lylie Gisèle Atsafack Mboudem, Sylvie Léa Wansi Ngnokam · 2026 · Comparative Clinical Pathology
  25. Evaluation of Repeated Biomarkers: Non-parametric Comparison of Areas under the Receiver Operating Curve Between Correlated Groups Using an Optimal Weighting Scheme
    Ping Xu · 2012 · Digital Commons - University of South Florida (University of South Florida)
  26. Update on Genetic Determinants of Type1 Diabetes
    Philippe Antoine Lysy · 2016 · Journal of Molecular and Genetic Medicine
  27. An overview of tolerogenic immunotherapies based on plant-made antigens
    Dania O. Govea‐Alonso, Jaime I. Arévalo-Villalobos, Verónica Araceli Márquez-Escobar, Sornkanok Vimolmangkang, Sergio Rosales‐Mendoza · 2019 · Expert Opinion on Biological Therapy
  28. Pathogenesis of Type 1 Diabetes
    Alberto Pugliese · 2018 · Endocrinology
  29. Mechanisms of transcriptional regulation in the maintenance of β cell function
    Aarthi V. Maganti · 2015 · IUScholarWorks (Indiana University)
  30. Inflammatory mechanisms associated with type 1 diabetes mellitus and oral diseases
    Radhika Desai · 2017
  31. Prevention of Type 1 Diabetes
    Jay S. Skyler · 2018 · Endocrinology
  32. Current literature in diabetes
    2010 · Diabetes/Metabolism Research and Reviews
  33. Successes and Disappointments with Clinical Islet Transplantation
    Paolo Cravedi, Piero Luigi Ruggenenti, Giuseppe Remuzzi · 2014 · Springer eBooks
  34. Faculty Opinions recommendation of Early prediction of autoimmune (type 1) diabetes.
    Carla J. Greenbaum, Sandra M. Lord · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  35. Literatur
    2012 · Elsevier eBooks
  36. Fallimento β-cellulare nel diabete mellito di tipo 1 e di tipo 2: esistono meccanismi comuni?
    Nicola Marrano, Giuseppina Biondi, Francesco Giorgino, Annalisa Natalicchio · 2022 · il Diabete
  37. The Story of Diabetes and its Causes
    Ramin Malboosbaf, Neda Hatami · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  38. Immunotherapies for Type 1 Diabetes
    Jesper Johannesen, Flemming Pociot · 2024
  39. Additional file 1 of High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies
    Maya Nitecki, Gerstein, Hertzel C., Yulia Balmakov, Eyal Tsur, Vladislav Babushkin, Tomer Michaeli, Afek, Arnon, Pinhas-Hamiel, Orit, Tali Cukierman‐Yaffe, Gilad Twig · 2024 · Figshare
  40. C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes
    Emily Kristen Sims, Jay S. Skyler, Laura M. Jacobsen, Heba M. Ismail, MARIA JOSE REDONDO, Brandon M. Nathan, David Cuthbertson, Jay M. Sosenko · 2026 · Diabetes Care
  41. Stages of Type 1 Diabetes and New Interventions (Teplizumab)
    Marcelo Maia Pinheiro · 2026 · Contemporary Endocrinology